During subsequent follow-up, consistently elevated levels of C8 and C8/C10 were observed, and high-throughput sequencing did not reveal any additional genetic metabolic disorders associated with elevated C8 (including variations in the ETFA, ETFB, and ETFDH genes). The gene discussed is ETFDH; the disease is metabolic disease.